Last, we establish an animal model of GNAO1 encephalopathy and show that a dietary supplementation of Zn2+, the active component of the treatment, provides a significant rescue of the movement disorder and life-span shortening of the mutant animals. This evidence concerns the gene GNAO1 and movement disorder.